Tag: Global Injection Pen Market

Injection Pen Market
Healthcare

Injection Pen Market: Patent Expiry of Biologics to Drive the Demand for Biosimilars

The growth of this market is primarily driven by factors such as the growing prevalence of chronic diseases, increasing number of regulatory approvals, and favorable reimbursement in developed countries, and government support. The global injection pen market is projected to reach USD 41.38 Billion by 2022 from USD 30.97 Billion in 2017 at a CAGR of 6.0% during the forecast period. Market is segmented on the basis … Continue reading Injection Pen Market: Patent Expiry of Biologics to Drive the Demand for Biosimilars

Unknown's avatarRitika Tyagi
Injection Pen Market
Biotechnology, Healthcare, Medical Devices, Pharmaceuticals

Global Injection Pen Market Dominated by Novo Nordisk (Denmark), Eli Lilly (US), and Sanofi (France)

Rising prevalence of chronic diseases, favorable reimbursement scenario and government support, and the increasing number of regulatory approvals resulting in the increased adoption among patients. The global injection pen market is expected to reach $41.38 Billion by 2022 from $30.97 Billion in 2017, at a CAGR of 6.0%. Segments The market is segmented on the basis of type, therapy, end user, and region. Based on type, the market is segmented … Continue reading Global Injection Pen Market Dominated by Novo Nordisk (Denmark), Eli Lilly (US), and Sanofi (France)

Unknown's avatarRitika Tyagi